Mulundocandin, an echinocandin-like lipopeptide antifungal agent: Biological activities in vitro

Journal of Antibiotics

Volumn 52, Issue 3, 1999, Pages 305-310

  Hawser, Stephen ^a   Borgonovi, Monica ^a   Markus, Astrid ^a   Isert, Dieter ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; LIPOPEPTIDE; MULUNDOCANDIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DOSE TIME EFFECT RELATION; FUNGICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SERUM; TRICHOPHYTON; YEAST;

ASPERGILLUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CRYPTOCOCCUS NEOFORMANS; TRICHOPHYTON;

EID: 0032937995     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.305     Document Type: Article

References (10)

1. FAN HARVARD, P.; D. CAPANA, S. M. SMITH, A. MANGIA & R. H. K. ENG: Development of resistance in Candida isolates from patients receiving prolonged anti-fungal therapy. Antimicrob. Agents Chemother. 35: 2302-2305, 1991
2. RUHNKE, M.; A. EIGLER, I. TENNAGEN, B. GEISELER, E. ENGELMANN & M. TRAUTMANN: Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32: 2092-2098, 1994
3. TAKESAKO, K.; K. IKAI, F. HARUNA, M. ENDO, K. SHIMANAKA, E. SONO, T. NAKAMURA & H. YAMAGUCHI: Aureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties. J. Antibiotics 44: 919-924, 1991
4. SCHMATZ, D. M.; G. ABRUZZO, M. A. POWLES, D. C. MCFADDEN, J. M. BALKOVEC, R. M. BLACK, K. NOLLSTADT & K. BARTIZAL: Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species. J. Antibiotics 45: 1886-1891, 1992
5. BALKOVEC, J. M.: Lipopeptide antifungal agents. Exp. Opin. Invest. Drugs 3: 65-82, 1994
6. MUKHOPADHYAY, T.; K. ROY, R. G. BHAT, S. N. SAWANT, J. BLUMBACH, B. N. GANGULI & H. W. FEHLHABER: Deoxymulundocandin-A new echinocandin type antifungal antibiotic. J. Antibiotics 45: 618-623, 1992
7. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeast; approved standard, M27-A. NCCLS, Wayne, PA
8. HAWSER, S. P. & K. ISLAM: Spectrophotometric determination of the morphogenetic transformation by synchronous Candida albicans: effects of antifungal agents. J. Antimicrob. Chemother. 38: 67-73, 1996
9. KLEPSER, M. E., E. J. ERNST, M. E. ERNST & M. A. PFALLER: Growth medium effect on the antifungal activity of LY303366. Diagn. Microbiol. Infect. Dis. 29: 227-231, 1997
10. FROSCO, M.; L. E. LAWRENCE & J. F. BARRETT: Meetings Highlights. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Exp. Opin. Invest. Drugs 6: 1951-1968, 1997